Financials
Financial year 2025
PHARMACIE DEFRE from Celles (lez-Tournai), company number BE0480024492, closed financial year 2025 with a result of € 72,183 after tax. For that financial year PHARMACIE DEFRE recorded a gross margin of € 350,376 and equity of € 353,809. Compared with financial year 2024, the result moved from € 58,682 to € 72,183. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 353,809
▲ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 72,183
▲ 23% vs 2024
Profit after tax over the fiscal year.
€ 83,207
▲ 147% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 50,000 paid out
69 % of the profit went to the shareholders, mostly to LES PHARMACIES RURALES (100 % of the shares). That is where the money ends up.
People and assets in 2025
2.3
Average over the fiscal year, from the social balance sheet.
€ 200,479
▲ 20% vs 2024
€ 87,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,707
▼ 57% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 221,310
▼ 17% vs 2024
€ 47,822 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 414,282
▲ 10% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 46,930
▼ 1% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 376,090 | € 347,372 | € 303,812 | € 350,376 | ▲ 15% |
| Profit after taxes | € 116,635 | € 65,336 | € 58,682 | € 72,183 | ▲ 23% |
| Equity | € 262,607 | € 307,943 | € 331,625 | € 353,809 | ▲ 7% |
| Total debts | € 962,820 | € 878,842 | € 819,509 | € 803,243 | ▼ 2% |
| Cash | € 100,206 | € 34,115 | € 33,682 | € 83,207 | ▲ 147% |
| Land & buildings | € 346,988 | € 319,217 | € 291,445 | € 263,674 | ▼ 10% |
| Retained profit | € 212,607 | € 257,943 | € 281,625 | € 303,809 | ▲ 8% |
| Dividend | € 60,000 | € 20,000 | € 35,000 | € 50,000 | ▲ 43% |
| Bank debt | € 348,078 | € 305,557 | € 265,345 | € 221,310 | ▼ 17% |
| Balance sheet total | € 1,225,426 | € 1,186,785 | € 1,151,134 | € 1,157,052 | ▲ 1% |
| Employees (FTE) | 2.5 | 2.4 | 2.3 | 2.3 |
Key figures of PHARMACIE DEFRE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE DEFRE?
What happened at PHARMACIE DEFRE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 72,183 (▲ 23% vs 2024). filed late Source: NBB ↗
- BLUESTONE SRL became a director. NBB
- New establishment in Ukkel. KBO
- Start of the company according to the CBE. KBO
In short
From € 116,635 profit in 2022 to € 72,183 profit in 2025.
Paid € 60,441 in corporate taxes since 2022.
Best year ever: 2022, with € 116,635 profit.
On average € 152,300 of value added per employee in 2025.
A new publication or filing at PHARMACIE DEFRE? We notify you, reason included.
Follow PHARMACIE DEFREDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of LES PHARMACIES RURALES comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE DEFREBehind PHARMACIE DEFRE is BLUESTONE SRL. The shares are held by LES PHARMACIES RURALES (100%). It owns 21% of PHARMACIE DU PESAGE SA and 6.7% of PHARMIMPULSE GIE itself.
Directors
According to the 2025 annual accounts
Director · represented by Paul RANSART
Also active at: COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE, PHARMACIE de BARRY, PALATINE, LENANS, IMMOLENANS, ANCIAUX, DIGITALE, DELTAPHAR +6 more
since 2022
Shareholders
Participations
Establishments
Establishment units
Physical locations of this company
Place de Velaines (VEL) 13
7760 Celles (lez-Tournai)
De Frélaan 179
1180 Ukkel
Active since 16 May 2003
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0480.024.492
- VAT number
- BE 0480.024.492
- Registered office
- Place de Velaines (VEL) 13, 7760 Celles (lez-Tournai)
- Names & denominations
- PHARMACIE DEFRE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 April 2003
- Peppol
- Active · Active since 20 Oct 2025
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten